NCT06595264

Brief Summary

  1. 1.Foundations of the clinical research project:
  2. 2.Objectives of the clinical research project:
  3. 3.Methodology of the clinical research project:
  4. 4.Design of the clinical research project:
  5. 5.Participants:

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

September 10, 2024

Last Update Submit

May 20, 2025

Conditions

Keywords

vein of Galen aneurysmneuroradiological embolization

Outcome Measures

Primary Outcomes (1)

  • Neurological outcome

    Neurological outcome after each embolization therapy will be recorded (%): No neurological deficit, minor neurological deficit, major neurological deficit

    28 days

Secondary Outcomes (2)

  • Cardiac failure

    28 days

  • Inotropic support

    28 days

Study Arms (1)

Vein of Galen malformation

All patients treated at Erasme hospital for a vein of Galen malformation.

Procedure: embolization therapy

Interventions

Embolization in the neuroradiological department is the Golden Standard for the treatment of vein of Galen malformations.

Vein of Galen malformation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients treated at Erasme for a vein of Galen malformation up to august 2024

You may qualify if:

  • \- All patients treated at Erasme for a vein of Galen malformation

You may not qualify if:

  • \- Opposition of parents to the use of medical data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

H.U.B - Hôpital Erasme

Brussels, 1070, Belgium

Location

Related Publications (3)

  • Ashida Y, Miyahara H, Sawada H, Mitani Y, Maruyama K. Anesthetic management of a neonate with vein of Galen aneurysmal malformations and severe pulmonary hypertension. Paediatr Anaesth. 2005 Jun;15(6):525-8. doi: 10.1111/j.1460-9592.2005.01471.x.

    PMID: 15910357BACKGROUND
  • Sinha PK, Neema PK, Rathod RC. Anesthesia and intracranial arteriovenous malformation. Neurol India. 2004 Jun;52(2):163-70.

    PMID: 15269462BACKGROUND
  • Mortazavi MM, Griessenauer CJ, Foreman P, Bavarsad Shahripour R, Shoja MM, Rozzelle CJ, Tubbs RS, Fisher WS 3rd, Fukushima T. Vein of Galen aneurysmal malformations: critical analysis of the literature with proposal of a new classification system. J Neurosurg Pediatr. 2013 Sep;12(3):293-306. doi: 10.3171/2013.5.PEDS12587. Epub 2013 Jul 26.

    PMID: 23889354BACKGROUND

MeSH Terms

Conditions

Vein of Galen MalformationsVein of Galen aneurysm

Interventions

Embolization, Therapeutic

Condition Hierarchy (Ancestors)

Intracranial Arteriovenous MalformationsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCentral Nervous System Vascular MalformationsNervous System MalformationsArteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular DiseasesIntracranial Arterial DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Hemostatic TechniquesTherapeuticsTherapeutic Occlusion

Study Officials

  • Denis Schmartz, MD

    Université Libre de Bruxelles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion

April 30, 2025

Study Completion

May 15, 2025

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations